• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标题:截短侧耳素衍生物的设计、合成与抗菌活性研究。

Design, synthesis and antibacterial activities of pleuromutilin derivatives.

机构信息

College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.

College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.

出版信息

J Asian Nat Prod Res. 2021 Feb;23(2):123-137. doi: 10.1080/10286020.2020.1713764. Epub 2020 Feb 6.

DOI:10.1080/10286020.2020.1713764
PMID:32024387
Abstract

We described the design, synthesis and antimicrobial activities of novel pleuromutilin derivatives with substituted piperazine substrate. Minimum inhibitory concentration (MIC) was used to evaluate the activity of the derivatives against six bacteria , and compound was potent against and with the MIC value of 0.0625 μg/ml. and showed similar activity to positive control drugs (tiamulin, erythromycin) against with the MIC value of 0.125 μg/ml. The binding mode of compound and tiamulin to the ribosome pocket showed the correlation between binding parameters and the antibacterial activity, and more bonds and stronger combination could effectively enhance the activity of compounds.[Formula: see text].

摘要

我们描述了具有取代哌嗪底物的新型截短侧耳素衍生物的设计、合成和抗菌活性。最小抑菌浓度(MIC)用于评估衍生物对六种细菌的活性,化合物对 和 具有很强的活性,MIC 值为 0.0625μg/ml。 和 对 与阳性对照药物(泰妙菌素、红霉素)的活性相似,MIC 值为 0.125μg/ml。化合物 和泰妙菌素与核糖体口袋的结合模式表明结合参数与抗菌活性之间存在相关性,更多的键和更强的结合可以有效增强化合物的活性。[化学式:见正文]。

相似文献

1
Design, synthesis and antibacterial activities of pleuromutilin derivatives.标题:截短侧耳素衍生物的设计、合成与抗菌活性研究。
J Asian Nat Prod Res. 2021 Feb;23(2):123-137. doi: 10.1080/10286020.2020.1713764. Epub 2020 Feb 6.
2
Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.截短侧耳素衍生物的设计、合成及抗菌活性评价
Bioorg Med Chem. 2022 Apr 1;59:116676. doi: 10.1016/j.bmc.2022.116676. Epub 2022 Feb 23.
3
Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.新型含哌嗪和 1,2,3-三唑连接子的截短侧耳素衍生物的设计、合成与生物评价。
Bioorg Chem. 2020 Dec;105:104398. doi: 10.1016/j.bioorg.2020.104398. Epub 2020 Oct 21.
4
Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.新型截短侧耳素衍生物的设计、合成及作为靶向 50S 核糖体的抗耐甲氧西林金黄色葡萄球菌(MRSA)药物的生物评价。
Bioorg Med Chem. 2021 May 15;38:116138. doi: 10.1016/j.bmc.2021.116138. Epub 2021 Apr 2.
5
Discovery of 1,2,3-triazole-based pleuromutilin derivatives as potent gram-positive antibacterial agents.发现基于 1,2,3-三氮唑的截短侧耳素衍生物是有效的革兰氏阳性菌抗菌剂。
Bioorg Med Chem Lett. 2024 Sep 15;110:129878. doi: 10.1016/j.bmcl.2024.129878. Epub 2024 Jul 6.
6
Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.具有巯基乙胺连接基的截短侧耳素衍生物的合成及其对耐甲氧西林金黄色葡萄球菌的抗菌活性
Med Chem. 2018;14(6):585-594. doi: 10.2174/1573406414666180416131737.
7
Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with thieno[2,3-d]pyrimidine substitution.新型含噻吩并[2,3-d]嘧啶取代的截短侧耳素衍生物的设计、合成与抗菌活性。
Eur J Med Chem. 2022 Jul 5;237:114398. doi: 10.1016/j.ejmech.2022.114398. Epub 2022 Apr 19.
8
Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups.设计、合成、含有氮杂环和烷基胺基团的新型截短侧耳素衍生物的生物评价和分子对接研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2078-2091. doi: 10.1080/14756366.2022.2104267.
9
Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1-pyrazolo[3,4-]pyrimidine-4-amino Side Chain.新型含 6-氯-1-R-1-吡唑并[3,4-d]嘧啶-4-氨基侧链的截短侧耳素衍生物的设计、合成与生物评价。
Molecules. 2023 May 8;28(9):3975. doi: 10.3390/molecules28093975.
10
Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.设计、合成及生物评价截短侧耳素席夫碱杂合体作为潜在的抗耐甲氧西林金黄色葡萄球菌药物:体外和体内研究。
Eur J Med Chem. 2021 Nov 5;223:113624. doi: 10.1016/j.ejmech.2021.113624. Epub 2021 Jun 12.

引用本文的文献

1
Design and Synthesis of Pleuromutilin Derivatives as Antibacterial Agents Using Quantitative Structure-Activity Relationship Model.利用定量构效关系模型设计和合成截短侧耳素衍生物作为抗菌剂。
Int J Mol Sci. 2024 Feb 13;25(4):2256. doi: 10.3390/ijms25042256.
2
Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.硫鸟嘌呤修饰的截短侧耳素衍生物的设计、合成及生物活性
ACS Med Chem Lett. 2023 May 10;14(6):737-745. doi: 10.1021/acsmedchemlett.3c00004. eCollection 2023 Jun 8.
3
Synthesis, biological assessment, and computational investigations of nifedipine and monastrol analogues as anti-leishmanial major and anti-microbial agents.
合成、生物评估和计算研究硝苯地平和单端孢菌素类似物作为抗利什曼原虫主要药物和抗微生物药物。
Mol Divers. 2023 Dec;27(6):2555-2575. doi: 10.1007/s11030-022-10569-4. Epub 2022 Nov 22.
4
Piperazine skeleton in the structural modification of natural products: a review.哌嗪骨架在天然产物结构修饰中的应用:综述。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1165-1197. doi: 10.1080/14756366.2021.1931861.